spacer
home > pmps > spring 2017 > under control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Under Control

A controlled substance is a drug or chemical whose manufacture, possession or distribution is highly regulated by the government and subject to legislative control. They include illegal drugs, prescription medications and chemicals considered as precursors to the production of illegal drugs. These are all believed to cause harm to an individual if not used properly. Their manufacture and distribution are closely monitored by the United Nations (UN).

The construction of an international legal framework for controlled drugs has gone through several stages of development since the 1920 alcohol prohibition in the US. In 1961, the Single Convention on Narcotic Drugs was established as a universal system to limit the cultivation, production, distribution, trade, use and possession of narcotic substances strictly for medical and scientific purposes, with special attention to those produced from plants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Rich Nelson is the Distribution Services Manager for PCI’s Clinical Services group, working with clients to provide seamless global distribution of their investigational products. He joined the company in 2012 after seven years with Fisher Clinical Services, having supported both global distribution for investigational products, as well as interactive voice response solutions. Rich is certified in Lean Six Sigma/continuous improvement, including as a Small Group Facilitor/ Corporate Trainer, and is a graduate of Monmouth University, US.
spacer
Rich Nelson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Strategic Alliance to support efficient, ethical practices in biopharma industry

Hayward, CA and Stockholm, Sweden (07-12-2017) – Two leading drug development and regulatory consultancies announced today that they have formed a new strategic collaboration to help life science companies navigate an increasingly complex global environment. Ethiprax Associates LLC, a leading Compliance and Ethics solutions consultancy based in the US, and NDA Group, a world-leading integrated regulatory/drug development consultancy, are now collaborating to provide the life science industry with truly integrated, trans-Atlantic Compliance-and Risk Management strategies.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 
Industry Events

12th annual Cold Chain Distribution Conference and Exhibition

13-14 December 2017, Copthorne Tara Hotel, London, UK

Responding to the evolution within the industry, SMi is proud to announce the return of its leading 12th annual Cold Chain Distribution event. Returning to London in December, this year's event will remain at the forefront of innovation
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement